RareResearch.AI
← Back to atlas

N849K

Category 3/4 — Most DruggableUncertain significanceLumenal · predictedσ-1 candidateSource card
AsparagineLysine at position 849 · C-terminal ER-lumenal (calcium binding, calmodulin, chaperone) · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type N849 — hydrogen bond to L822
Fullscreen ↗
DynaMut2 mutant · N849K
Mutant K849 — hydrogen bond to L822 lost (4 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

4 lost0 gained2 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondL822L822Preserved
Polar contactS821Lost
Polar contactL822Lost
Van der WaalsS821Lost
Van der WaalsL822Lost
HydrophobicL822L822Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-0.06kcal/mol
Destabilising — mild
AlphaMissense
0.864
likely pathogenic
AlphaFold pLDDT
83
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, single submitter
Associated conditions
Population frequency (gnomAD v4)Ultra-rare · AF 0.00012%
cDNA changec.2547C>G
ClinVar accessionVCV004706420
Last evaluated2025/06/10 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — N849K Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Asparagine → Lysine at position 849. C-terminal ER-lumenal (calcium binding. ClinVar Uncertain significance, AlphaMissense 0.864, DynaMut2 ΔΔG -0.06 kcal/mol (destabilising).


Identity

FieldValue
VariantN849K (p.Asparagine849Lysine)
DNA changec.2547C>G
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV004706420
Amino acid changeAsparagine (N) → Lysine (K)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 84983.00 — well-folded
DomainC-terminal ER-lumenal (calcium binding, calmodulin, chaperone)
Position contextC-terminal lumenal domain · position 849 projects into the ER lumen
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 849 sits in the C-terminal lumenal domain (residues 653–869), wolframin's largest soluble region. This domain projects into the ER lumen and is implicated in calcium handling, ER stress sensing, and protein–protein interactions with ATF6 and Na+/K+ ATPase β1. The wild-type residue is polar amide (asparagine — H-bond donor/acceptor); the mutant is positively charged (lysine — primary amine). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.8644
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)-0.06 (Destabilising)
Job ID178092110871
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092110871

Clinical Evidence

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, single submitter
Last evaluated2025/06/10 00:00
InheritanceInheritance pattern not specified in ClinVar entry; WFS1 has both AD and AR presentations.
WFS1 variant landscapeN849K is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

(no conditions catalogued)


Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=0.06 < 2 kcal/mol (fold intact) + AlphaMissense 0.864 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.06 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.864. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • N849K_molstar_viewer.html — interactive 3D viewer (auto-highlights position 849 with ball-and-stick + neighbors within 5Å)
  • N849K_variant_card.md — this card (source of truth)
  • N849K_variant_card.html — styled printable card
  • N849K_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • N849K_wildtype_interactions.pse / N849K_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the N849K PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download N849K PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.